Better or worse? The prognostic role of the mesenchymal subtype in patients with high‐grade serous ovarian carcinoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Better or worse? The prognostic role of the mesenchymal subtype in patients with high‐grade serous ovarian carcinoma: A systematic review and meta‐analysis

Published:2022-04-17 Issue:20 Volume:11 Page:3761-3770
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Chen Juan¹,Shi Xiaoyan²,Xiao Lan¹^ORCID,Li Zelian¹,Li Zhimin³,Sun Lei¹

Affiliation:

1. Department of Obstetrics & Gynecology First Affiliated Hospital of Anhui Medical University Hefei China

2. Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Department of Gynecology Guangdong Women and Children Hospital Guangzhou China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4752

Reference48 articles.

1. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Cancer Statistics, 2021

4. National Institute for Health and Care Excellence (NICE).Ovarian cancer: the recognition and initial management of ovarian cancer. NICE 2011 Apr:CG122. Accessed February 2 2021.https://www‐nice‐org‐uk.acces.bibl.ulaval.ca/guidance/cg122/resources/ovarian‐cancer‐recognition‐and‐initial‐management‐35109446543557

5. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Subtypes of High-Grade Serous Ovarian Carcinoma;Interdisciplinary Cancer Research;2022